Starpharma today announced the appointment of Ms Zita Peach as a Non-Executive Director.

Zita has more than 20 years of commercial experience in the pharmaceutical industry, particularly in marketing and business development, working for major industry players such as CSL Limited and Merck Sharp & Dohme (MSD), the Australian subsidiary of Merck Inc.

Starpharma  has received notification that it will be elevated to the S&P/ASX 300 Index, effective from 19^th September.